Historical salary details - Dr. George D. Yancopoulos,M.D.,PhD, Co-Chairman of the Board, Co-President and Chief Scientific Officer, Regeneron Pharmaceuticals, Inc.
Dr. George D. Yancopoulos,M.D.,PhD has been the Co-Chairman of the Board, Co-President and Chief Scientific Officer of Regeneron Pharmaceuticals, Inc. since 07 Feb 2001. View his historical salary.
Dr. George D. Yancopoulos,M.D.,Phd
Co-Chairman of the Board, Co-President and Chief Scientific Officer
-
Gross Remuneration
-
Current Company
Regeneron Pharmaceuticals, Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Regeneron Pharmaceuticals, Inc. | Co-Chairman of the Board, Co-President and Chief Scientific Officer | - | - |
| 2023 | Regeneron Pharmaceuticals, Inc. | Co-Chairman of the Board, Co-President and Chief Scientific Officer | 7.8 M | 17.7 % |
| 2023 | Regeneron Pharmaceuticals, Inc. | Co-Chairman of the Board, Co-President and Chief Scientific Officer | - | - |
| 2022 | Regeneron Pharmaceuticals, Inc. | Director, Co-President and Chief Scientific Officer | 6.6 M | 3.1 % |
| 2021 | Regeneron Pharmaceuticals, Inc. | - | 6.4 M | -95.2 % |
| 2021 | Regeneron Pharmaceuticals, Inc. | Director, Co-President and Chief Scientific Officer | 6.4 M | -95.2 % |
| 2020 | Regeneron Pharmaceuticals, Inc. | - | 134.4 M | 550.3 % |
| 2020 | Regeneron Pharmaceuticals, Inc. | Director, Co-President and Chief Scientific Officer | 134.4 M | 550.3 % |
| 2020 | Regeneron Pharmaceuticals, Inc. | - | 134.4 M | 550.3 % |
| 2019 | Regeneron Pharmaceuticals, Inc. | - | 20.7 M | -18.6 % |
| 2019 | Regeneron Pharmaceuticals, Inc. | Director, President and Chief Scientific Officer | 20.7 M | -18.6 % |
| 2019 | Regeneron Pharmaceuticals, Inc. | - | 20.7 M | -18.6 % |
| 2018 | Regeneron Pharmaceuticals, Inc. | - | 25.4 M | 0.3 % |
| 2018 | Regeneron Pharmaceuticals, Inc. | - | 25.4 M | 0.3 % |
| 2018 | Regeneron Pharmaceuticals, Inc. | Director, President and Chief Scientific Officer | 25.4 M | 0.3 % |
| 2017 | Regeneron Pharmaceuticals, Inc. | - | 25.3 M | -8.9 % |
| 2017 | Regeneron Pharmaceuticals, Inc. | Director, President and Chief Scientific Officer | 25.3 M | -8.9 % |
| 2017 | Regeneron Pharmaceuticals, Inc. | - | 25.3 M | -8.9 % |
| 2016 | Regeneron Pharmaceuticals, Inc. | - | 27.8 M | -31.1 % |
| 2016 | Regeneron Pharmaceuticals, Inc. | Director, President and Chief Scientific Officer | 27.8 M | -31.1 % |
| 2016 | Regeneron Pharmaceuticals, Inc. | - | 27.8 M | -31.1 % |
| 2015 | Regeneron Pharmaceuticals, Inc. | - | 40.3 M | 13.5 % |
| 2015 | Regeneron Pharmaceuticals, Inc. | - | 40.3 M | 13.5 % |
| 2015 | Regeneron Pharmaceuticals, Inc. | Director, President, Regeneron Laboratories and Chief Scientific Officer | 40.3 M | 13.5 % |
| 2014 | Regeneron Pharmaceuticals, Inc. | - | 35.5 M | 14.5 % |
| 2014 | Regeneron Pharmaceuticals, Inc. | Director, President, Regeneron Laboratories and Chief Scientific Officer | 35.5 M | 14.5 % |
| 2014 | Regeneron Pharmaceuticals, Inc. | - | 35.5 M | 14.5 % |
| 2013 | Regeneron Pharmaceuticals, Inc. | - | 31.0 M | -62.0 % |
| 2013 | Regeneron Pharmaceuticals, Inc. | Director, President, Regeneron Laboratories and Chief Scientific Officer | 31.0 M | -62.0 % |
| 2013 | Regeneron Pharmaceuticals, Inc. | - | 31.0 M | -62.0 % |
| 2012 | Regeneron Pharmaceuticals, Inc. | - | 81.6 M | 713.3 % |
| 2012 | Regeneron Pharmaceuticals, Inc. | - | 81.6 M | 713.3 % |
| 2012 | Regeneron Pharmaceuticals, Inc. | Chief Scientific Officer, President, Regeneron Research Laboratories and Director | 81.6 M | 713.3 % |
| 2011 | Regeneron Pharmaceuticals, Inc. | - | 10.0 M | -24.9 % |
| 2011 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories, and | 10.0 M | -24.9 % |
| 2011 | Regeneron Pharmaceuticals, Inc. | - | 10.0 M | -24.9 % |
| 2010 | Regeneron Pharmaceuticals, Inc. | - | 13.4 M | 161.4 % |
| 2010 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories, and | 13.4 M | 161.4 % |
| 2010 | Regeneron Pharmaceuticals, Inc. | - | 13.4 M | 161.4 % |
| 2009 | Regeneron Pharmaceuticals, Inc. | - | 5.1 M | 162.8 % |
| 2009 | Regeneron Pharmaceuticals, Inc. | - | 5.1 M | 162.8 % |
| 2009 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories, and | 5.1 M | 162.8 % |
| 2008 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President of Regeneron Research Laboratories and Director | 5.6 M | 59.0 % |
| 2008 | Regeneron Pharmaceuticals, Inc. | - | 1.9 M | -45.2 % |
| 2008 | Regeneron Pharmaceuticals, Inc. | - | 1.9 M | -45.2 % |
| 2007 | Regeneron Pharmaceuticals, Inc. | - | 14.9 M | 495.2 % |
| 2007 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President of Regeneron Research Laboratories and Director | 3.5 M | 42.1 % |
| 2007 | Regeneron Pharmaceuticals, Inc. | - | 3.5 M | 42.1 % |
| 2006 | Regeneron Pharmaceuticals, Inc. | - | 2.5 M | - |
| 2006 | Regeneron Pharmaceuticals, Inc. | - | 2.5 M | - |
| 2006 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories and Director | 2.5 M | - |
| 2005 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories and Director | - | - |
| 2004 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2004 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories and Director | - | - |
| 2003 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2003 | Regeneron Pharmaceuticals, Inc. | Executive Vice President, Chief Scientific Officer, President, Regeneron Research Laboratories and Director | - | - |
| 2003 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2002 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2002 | Regeneron Pharmaceuticals, Inc. | Director, Executive Vice President, Chief Scientific Officer and President of Research Laboratories | - | - |
| 2002 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2001 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2001 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2001 | Regeneron Pharmaceuticals, Inc. | Director, Executive Vice President, Chief Scientific Officer and President, Research Laboratories | - | - |
| 2000 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2000 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 2000 | Regeneron Pharmaceuticals, Inc. | Director, Executive Vice President, Chief Scientific Officer, President of Regeneron Research Laboratories | - | - |
| 1999 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 1999 | Regeneron Pharmaceuticals, Inc. | - | - | - |
| 1998 | Regeneron Pharmaceuticals, Inc. | - | - | - |